News
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
"There are only a handful of people in the world who have experience in running a direct-to-consumer genetic testing company ...
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...
Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...
TTAM Research Institute - 23andMe's co-founder and former CEO Anne Wojcicki's new company - is the winner in a final round of ...
Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...
Oklahoma Attorney General Gentner Drummond filed a federal lawsuit to block 23andMe, a genetic testing company, from selling ...
A significant change is underway in the field of personal genomic testing, as early leaders like 23andMe, AncestryDNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback